119 related articles for article (PubMed ID: 9862200)
1. A 2.3 A resolution structure of chymosin complexed with a reduced bond inhibitor shows that the active site beta-hairpin flap is rearranged when compared with the native crystal structure.
Groves MR; Dhanaraj V; Badasso M; Nugent P; Pitts JE; Hoover DJ; Blundell TL
Protein Eng; 1998 Oct; 11(10):833-40. PubMed ID: 9862200
[TBL] [Abstract][Full Text] [Related]
2. X-ray analyses of aspartic proteinases. IV. Structure and refinement at 2.2 A resolution of bovine chymosin.
Newman M; Safro M; Frazao C; Khan G; Zdanov A; Tickle IJ; Blundell TL; Andreeva N
J Mol Biol; 1991 Oct; 221(4):1295-309. PubMed ID: 1942052
[TBL] [Abstract][Full Text] [Related]
3. Functional implications of the three-dimensional structure of bovine chymosin.
Gilliland GL; Oliva MT; Dill J
Adv Exp Med Biol; 1991; 306():23-37. PubMed ID: 1812710
[TBL] [Abstract][Full Text] [Related]
4. The three-dimensional structure of recombinant bovine chymosin at 2.3 A resolution.
Gilliland GL; Winborne EL; Nachman J; Wlodawer A
Proteins; 1990; 8(1):82-101. PubMed ID: 2217166
[TBL] [Abstract][Full Text] [Related]
5. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
Veerapandian B; Cooper JB; Sali A; Blundell TL
J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
[TBL] [Abstract][Full Text] [Related]
6. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
[TBL] [Abstract][Full Text] [Related]
7. Can enzymes adopt a self-inhibited form? Results of x-ray crystallographic studies of chymosin.
Andreeva N; Dill J; Gilliland GL
Biochem Biophys Res Commun; 1992 Apr; 184(2):1074-81. PubMed ID: 1575726
[TBL] [Abstract][Full Text] [Related]
8. Characterization and study of a kappa-casein-like chymosin-sensitive linkage.
Callebaut I; Schoentgen F; Prat K; Mornon JP; Jollès P
Biochim Biophys Acta; 2005 May; 1749(1):75-80. PubMed ID: 15848138
[TBL] [Abstract][Full Text] [Related]
9. Engineering enzyme subsite specificity: preparation, kinetic characterization, and X-ray analysis at 2.0-A resolution of Val111Phe site-mutated calf chymosin.
Strop P; Sedlacek J; Stys J; Kaderabkova Z; Blaha I; Pavlickova L; Pohl J; Fabry M; Kostka V; Newman M
Biochemistry; 1990 Oct; 29(42):9863-71. PubMed ID: 2271625
[TBL] [Abstract][Full Text] [Related]
10. Camel and bovine chymosin: the relationship between their structures and cheese-making properties.
Langholm Jensen J; Mølgaard A; Navarro Poulsen JC; Harboe MK; Simonsen JB; Lorentzen AM; Hjernø K; van den Brink JM; Qvist KB; Larsen S
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):901-13. PubMed ID: 23633601
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and X-ray analysis of the Y75N mutant of Mucor pusillus pepsin complexed with inhibitor.
Badasso MO; Dhanaraj V; Wood SP; Cooper JB; Blundell TL
Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):770-2. PubMed ID: 15039581
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9A resolution.
Kamitori S; Ohtaki A; Ino H; Takeuchi M
J Mol Biol; 2003 Mar; 326(5):1503-11. PubMed ID: 12595261
[TBL] [Abstract][Full Text] [Related]
13. Protein engineering loops in aspartic proteinases: site-directed mutagenesis, biochemical characterization and X-ray analysis of chymosin with a replaced loop from rhizopuspepsin.
Nugent PG; Albert A; Orprayoon P; Wilsher J; Pitts JE; Blundell TL; Dhanaraj V
Protein Eng; 1996 Oct; 9(10):885-93. PubMed ID: 8931128
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
15. [Molecular dynamics analysis of chymosin conformations in solution and in crystalline environment].
Kashparov IV; Russ AV; Andreeva NS
Mol Biol (Mosk); 2002; 36(5):931-8. PubMed ID: 12391857
[TBL] [Abstract][Full Text] [Related]
16. X-ray structures of five renin inhibitors bound to saccharopepsin: exploration of active-site specificity.
Cronin NB; Badasso MO; J Tickle I; Dreyer T; Hoover DJ; Rosati RL; Humblet CC; Lunney EA; Cooper JB
J Mol Biol; 2000 Nov; 303(5):745-60. PubMed ID: 11061973
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the aspartic proteinase from Rhizomucor miehei at 2.15 A resolution.
Yang J; Teplyakov A; Quail JW
J Mol Biol; 1997 May; 268(2):449-59. PubMed ID: 9159482
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
[TBL] [Abstract][Full Text] [Related]
20. Domain flexibility in aspartic proteinases.
Sali A; Veerapandian B; Cooper JB; Moss DS; Hofmann T; Blundell TL
Proteins; 1992 Feb; 12(2):158-70. PubMed ID: 1603805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
